Versant Capital Management »

Upstream Bio shares owned by Versant Capital Management

Quarter-by-quarter ownership of Upstream Bio (UPB) shares owned by Versant Capital Management from 13F filings

Historical chart of Versant Capital Management investment in Upstream Bio

Tip: Access up to 7 years of quarterly data

All positions including Upstream Bio held by Versant Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Upstream Bio by Versant Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $10k 548 18.81
2025-06-30 $6.1k 558 10.98
2025-03-31 $3.8k 615 6.12

More positions owned by Versant Capital Management

Avantis International Equity Etf Etf (AVDE)
Avantis Emerging Markets Equity Etf Etf (AVEM)
Dimensional U.s. Core Equity 2 Etf Etf (DFAC)
Microsoft Stock (MSFT)
Flexshares Tr Mornstar Upstr Etf (GUNR)
Vaneck Gold Miners Etf Etf (GDX)
Dimensional International Core Equity 2 Etf Etf (DFIC)
Ishares S&p Global Energy Etf (IXC)
Global X Fds Global X Ftse Greece 20 Etf Etf (GREK)
Nvidia Corp Stock (NVDA)
Apple Stock (AAPL)
Vanguard Total Stk Mkt Etf (VTI)
Spdr S&p Global Natural Resources Etf Etf (GNR)
Dimensional Us Marketwide Value Etf Etf (DFUV)
Ishares Gold Trust Micro Etf Of Benef Interest Etf (IAUM)

View all positions for Versant Capital Management

Top funds holding Upstream Bio

FMR
OrbiMed Advisors
Decheng Capital
BlackRock
Enavate Sciences GP
Vanguard Group
Bain Capital Life Sciences Investors
TCG Crossover Management
Altshuler Shaham
Omega Fund Management
VR Adviser
Wellington Management Company
State Street Corporation
Samsara BioCapital
Marshall Wace

View all funds holding Upstream Bio